Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?
From MaRDI portal
Publication:4832007
Cites work
- scientific article; zbMATH DE number 3426675 (Why is no real title available?)
- scientific article; zbMATH DE number 3119645 (Why is no real title available?)
- scientific article; zbMATH DE number 48701 (Why is no real title available?)
- scientific article; zbMATH DE number 686769 (Why is no real title available?)
- scientific article; zbMATH DE number 3431652 (Why is no real title available?)
- scientific article; zbMATH DE number 3189754 (Why is no real title available?)
- scientific article; zbMATH DE number 3086542 (Why is no real title available?)
- Bayesian Approaches to Randomized Trials
- Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
- Inference for a Bernoulli Process (A Bayesian View)
- Monitoring Clinical Trials Based on Predictive Probability of Significance
- Papers on probability, statistics and statistical physics. Ed. by R. D. Rosenkrantz
- R. A. Fisher in the 21st century. Invited paper presented at the 1996 R. A. Fisher lecture. (With comments).
- Some Difficulties of Interpretation Encountered in the Application of the Chi-Square Test
- Specific inference in ANOVA: From significance tests to Bayesian procedures
- Statistical decision theory and Bayesian analysis. 2nd ed
- Theory of statistics
- USE OF PREDICTIVE PROBABILITIES IN PHASE II AND PHASE III CLINICAL TRIALS
Cited in
(4)
This page was built for publication: Uses, Abuses and Misuses of Significance Tests in the Scientific Community: Won't the Bayesian Choice be Unavoidable?
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q4832007)